Home Details
| Official Symbol of Gene | Il13 |
| Species | Mus musculus |
| Entrez Gene ID | 16163 |
| Official Full Name | interleukin 13 |
| Also known as | Il-13 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSMUSG00000020383 AllianceGenome:MGI:96541 |
| Map Location | 11 B1.3; 11 31.98 cM |
| Drug | IL-13 immune gene therapy (pCHMWS-IL-13-IRES-Pac LV plasmid) |
| Interaction Type | activator |
| Descent | C57BL/6J mice |
| Disease | MS |
| Pubmed ID | 27685637 |
| Year | 2016 |
| Title | Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages |
| Result | We provide evidence that IL-13 directs the polarization of both brain-resident microglia and infiltrating macrophages towards an alternatively activated phenotype, thereby promoting the conversion of a pro-inflammatory environment toward an anti-inflammatory environment.IL-13 immune gene therapy is also able to limit lesion severity in a pre-existing inflammatory environment. |
| Mechanism/pathway | lentiviral vector-mediated expression of the immune-modulating cytokine interleukin 13 (IL-13) induces an alternative activation program in both microglia and macrophages conferring protection against severe oligodendrocyte loss and demyelination in the cuprizone mouse model for multiple sclerosis (MS). |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.